News & Media2019-12-29T20:57:00+03:00

Announcements

Misraim announces the partnership with the giant Chinese Jiangso Henguri Pharmaceuticals. Misraim according to this partnership will be the Marketing Authorization Holder (MAH) for the novel anti-fungal, Caspofungin Acetate 50mg.  We are continuing our negotiation to involve other critical care [...]

January 9th, 2022|Categories: News|
Go to Top